WebbE-Mail Registrierung. Oder einloggen mit Webb27 jan. 2024 · VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced today that the Company has begun enrolling patients into the expansion cohort portion of the ongoing Phase 1 clinical trial for ZW49, its novel HER2 …
Zymeworks Showcases Preclinical Assets, Including New
Webb28 maj 2024 · Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that the Company will present a Webb8 juli 2024 · July 08, 2024 04:15 PM Eastern Daylight Time. VANCOUVER, British Columbia-- ( BUSINESS WIRE )--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical … isc lawyers
Zymeworks to Present at Raymond James Life Sciences and
Webb11 apr. 2024 · Tiffany Tolmie Manager, Investor Relations Phone: 604-419-3200 Email: [email protected] Media David Schull Russo Partners Phone: 858-717-2310 Email: [email protected] Source: Arbutus Biopharma Corporation Facebook LinkedIn Twitter Shareholder Tools Email AlertsEmail Alerts RSS News FeedsRSS News … Webb27 jan. 2024 · Investor Inquiries: Ryan Dercho, Ph.D. (604) 678-1388 [email protected] Tiffany Tolmie (604) 678-1388 [email protected] Media Inquiries: Mary Klem (604) … WebbTiffany Tolmie - Manager, Investor Relations - Zymeworks Inc. LinkedIn Tiffany Tolmie Manager, Investor Relations at Zymeworks Inc. (Mat Leave until October 2024) … sacred heart school tokyo